Grade My Investments

Bioventus Inc. (BVS) Stock Grade

BVS · Healthcare

A
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$495.7M
P/E Ratio
21.8
Revenue Growth (YoY)
-0.9%
Net Margin
4.0%
Return on Equity
12.3%
Dividend Yield
None

About Bioventus Inc.'s fundamentals

Bioventus is a medical devices company with a market capitalization of $495.7 million that trades at a P/E ratio of 21.8. The company experienced a slight revenue decline of 0.9% year-over-year, though it maintains a net profit margin of 4.0% and generates a return on equity of 12.3%. The company does not currently pay a dividend to shareholders.

Track BVS free — no credit card required. Live grade + monthly AI report →